News

Sheba Medical Center at Tel Hashomer, the largest hospital in the Middle East region, and Lonza, a leading global cell and gene therapy manufacturer, announced today that they have…
Read More...

Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently…
Read More...

GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology,  announced it has closed on a Series A financing generating…
Read More...

C4 Therapeutics, Inc. (C4T) a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through…
Read More...

Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the…
Read More...

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD 1 US) in Redmond, Washington. The innovative cGMP…
Read More...

Ceapro Inc. a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced that it has…
Read More...

I-Mab a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced positive interim data from its U.S. phase…
Read More...

Merck known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental…
Read More...

AzurRx BioPharma, Inc. a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, announced the completion of site…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a Memorandum of Understanding (MoU) with the government of Canada to build a…
Read More...

Aldevron, a leading research to GMP biomanufacturer of plasmid DNA, mRNA, and proteins, and Ginkgo Bioworks, Inc. ("Ginkgo") announced a manufacturing breakthrough driven by their…
Read More...

Seagen Inc. and RemeGen Co., Ltd. announced that the two companies have entered into an exclusive worldwide licensing agreement to develop and commercialize disitamab vedotin, a novel…
Read More...

To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation is excited to announce that its subsidiary, Dalrada Health, entered…
Read More...

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the European Union (EU) for the treatment of chronic kidney disease (CKD)…
Read More...

Fulgent Genetics, Inc. a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced that…
Read More...

Epizyme, Inc. a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, and HUTCHMED (China) Limited (“HUTCHMED”), announce a…
Read More...

The U.S. Food and Drug Administration (FDA) has approved Nexviazyme (avalglucosidase alfa-ngpt) for the treatment of patients one year of age and older with late-onset Pompe disease, a…
Read More...

Kite, a Gilead Company and Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer…
Read More...